help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abel, T. W.
Right arrow Articles by Rance, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abel, T. W.
Right arrow Articles by Rance, N. E.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 6 2111-2118
Copyright © 1999 by The Endocrine Society


Original Studies

The Effects of Hormone Replacement Therapy on Hypothalamic Neuropeptide Gene Expression in a Primate Model of Menopause1

Ty W. Abel2, Mary Lou Voytko and Naomi E. Rance

Departments of Pathology, Cell Biology and Anatomy, and Neurology (T.W.A., N.E.R.), University of Arizona College of Medicine, Tucson, Arizona 85724; and Department of Comparative Medicine (M.L.V.), Wake Forest School of Medicine, Winston-Salem, North Carolina 27157

Address all correspondence and requests for reprints to: Naomi E. Rance, M.D., Ph.D., Department of Pathology, University of Arizona College of Medicine, Tucson, Arizona 85724. E-mail: nrance{at}u.arizona.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Menopause is associated with increased neurokinin B (NKB) gene expression and decreased proopiomelanocortin (POMC) gene expression in the human hypothalamus. In the present study, young, ovariectomized cynomolgus monkeys were used in a model of menopause to examine the effects of hormone replacement therapy (HRT) on hypothalamic neuropeptide gene expression. A secondary goal was to determine whether HRT produces signs of estrogen toxicity in the primate hypothalamus by examining POMC neurons and microglial cells. In situ hybridization was performed using synthetic, radiolabeled, 48-base oligonucleotide probes. {alpha}-napthyl butyrate esterase histochemistry was used to visualize microglial cells. Both estrogen and estrogen plus progesterone treatments produced a marked suppression of the number of infundibular neurons expressing NKB gene transcripts. In contrast, HRT had no effect on the POMC system of neurons or the number of microglial cells in the infundibular nucleus. These results provide strong support for the hypothesis that the increased NKB gene expression in the hypothalamus of postmenopausal women is secondary to estrogen withdrawal. Conversely, these data suggest that the dramatic decline in the numbers of neurons expressing POMC gene transcripts in older women is caused by factors other than ovarian failure. Finally, we found no evidence that HRT, in doses designed to mimic currently prescribed regimens, produces signs of estrogen toxicity in the primate infundibular nucleus.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ESTROGEN and progesterone supplements are now among the most commonly prescribed drugs in the United States (1). Hormone replacement therapy (HRT) is administered for the prevention of osteoporosis, to lower the risk of cardiovascular disease and for the treatment of estrogen deficiency symptoms such as flushes and genitourinary atrophy (2). There are also data suggesting improved cognitive function (3) and a lowered risk of Alzheimer’s disease in women with hormone replacement (4). Low patient compliance with sequential replacement of hormones due to breakthrough endometrial bleeding has led to increased use of continuous nonphysiologic hormone replacement regimens (2, 5, 6). Although millions of women are currently receiving HRT, little is known about the effects of these treatments on the primate central nervous system.

Human menopause is associated with marked changes in hypothalamic neuronal morphology and neuropeptide gene expression (7, 8, 9, 10). There is somatic hypertrophy of neurons in the infundibular nucleus of postmenopausal women, which is characterized by enlarged nuclei and nucleoli and increased Nissl substance (rough endoplasmic reticulum) (7, 8). Postmenopausal neuronal hypertrophy occurs in a subpopulation of infundibular neurons expressing estrogen receptor, neurokinin B (NKB), and substance P gene transcripts (8, 9). There is a marked increase in the number of neurons expressing tachykinin gene transcripts (9), and gene expression also increases in a separate subpopulation of GnRH neurons within the medial basal hypothalamus (10). We have hypothesized that the dramatic increase in hypothalamic NKB gene expression in postmenopausal women is secondary to the ovarian failure of menopause.

More recently, we have described a decline in the number of neurons expressing proopiomelanocortin (POMC) messenger RNA (mRNA) in the infundibular nucleus of postmenopausal women (11). POMC is the precursor for ß-endorphin, which has been implicated in a variety of functions, including neuroendocrine and autonomic regulation, mood, memory, locomotion, reinforcement, and nociception (12, 13, 14, 15, 16). Other cleavage products of hypothalamic POMC include ACTH and {alpha}-MSH (17). These peptides have important physiological roles in the central nervous system as modulators of the immune response (18) and in the regulation of body weight (19, 20, 21). Thus, alterations in the function of the hypothalamic POMC system may have a considerable impact on the health of older women.

Because menopause is characterized by changes in both age and ovarian status, it is difficult to ascertain whether the changes in NKB and POMC gene expression in postmenopausal women are caused by hypothalamic aging or loss of ovarian hormones. To address this question, we used the young, ovariectomized cynomolgus monkey as a primate model of menopause to test the effects of hormone replacement on hypothalamic neuropeptide gene expression. If the changes observed in postmenopausal women are secondary to ovarian withdrawal, the replacement of ovarian hormones in ovariectomized monkeys should result in decreased numbers of NKB mRNA-expressing neurons, and conversely, increased numbers of POMC neurons in the monkey infundibular nucleus.

A second goal of the present study was to determine whether long-term HRT, in doses designed to mimic those currently prescribed to postmenopausal women, produces signs of estrogen toxicity in the primate hypothalamus. The toxic effects of long-term continuous estrogen treatment have been well described, and this toxicity produces a syndrome that resembles primary hypothalamic aging in the rat (22, 23). Although continuous HRT is currently prescribed to millions of women, it is not known whether a similar hypothalamic neuropathology occurs secondary to sustained estrogen exposure in primates. Therefore, we determined whether long-term HRT results in decreased numbers of POMC neurons and/or increased microglial activity in the primate infundibular nucleus. These two parameters were selected for study because they have been shown to be sensitive and specific markers of estrogen toxicity in the rat (23, 24).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animal treatments

Hypothalami were donated from monkeys enrolled in a study of the effects of HRT on coronary atherosclerosis conducted by the Comparative Medicine Clinical Research Center and the Department of Comparative Medicine at the Wake Forest School of Medicine (25). Animal treatments were carried out in compliance with state and federal laws, standards of the Department of Health and Human Services, and the guidelines of the Institutional Animal Care and Use Committee at the Wake Forest School of Medicine. Twenty-four adult female cynomolgus macaques (Macaca fascicularis) ranging in age from 5–13 yr were imported from Indonesia (Charles River Primates, Port Washington, NY). The monkeys were housed in social groups of 4–8 with indoor/outdoor facilities. Perches and barrels were provided for playing and hiding. The monkeys were ovariectomized under ketamine and xylazine anesthesia. All animals received a moderately atherogenic diet consisting of 43% of calories from fat and 0.44 mg cholesterol per kilocalorie. After 2 yr they were switched to a lipid-lowering diet for the remainder of the study. For a detailed description of the diet as well as plasma lipid profiles see Ref. 25 .

Two years after ovariectomy, the animals were divided into three experimental groups: untreated ovariectomized controls (OVX), continuous estrogen treatment (OVX +E), and estrogen plus progesterone (OVX + EP). Conjugated equine estrogen (Premarin, Wyeth-Ayerst Laboratories, Inc., Radnor, PA) was used for an initial treatment period of 7.2 µg/day for 8 months and then increased to 0.17 mg/day (per 4 kg BW). Medroxyprogesterone acetate (Cycrin, ESI Lederle, Philadelphia, PA) was given at a dose of 650 µg/day (per 4 kg BW). Based on adjustments for body size and metabolic rate, the final dosages were calculated to be equivalent to a women’s daily dose of 0.625 mg Premarin or 2.5 mg medroxyprogesterone. The hormones were administered twice daily in the diet. The animals received either HRT or no hormone treatment for a total of 30 months before death.

Plasma concentrations of 17ß-estradiol were determined in these animals 4 h after feeding, using a commercially available kit (Diagnostic Products Corporation, Los Angeles, CA). This assay had a sensitivity of 5–7 pg/mL. The mean plasma estradiol level in the OVX group was at the lower limit of sensitivity (5.1 ± 1.3 pg/mL). This value was significantly elevated in both the OVX + E (163.9 ± 18.9 pg/mL) and OVX + EP (147.6 ± 8.7 pg/mL) groups. For information concerning plasma levels of medroxyprogesterone in cynomolgus monkeys receiving these dosages, see Ref. 26 .

Animals were killed between 0900 and 1300 h. At this time, the animals were restrained with ketamine (15 mg/kg, im), deeply anesthetized with sodium pentobarbital (35 mg/kg, iv), and perfused transcardially with cold, 0.1 mol/L PBS (pH 7.4). The brains were rapidly removed and sliced into 1-cm slabs with the aid of a monkey brain matrix. A slab containing the hypothalamus was dissected by rostral cuts at the level of the optic chiasm and caudal cuts through the mammillary bodies. The hypothalami were dissected out of the slabs by a horizontal cut at the level of the anterior commissure and a parasagittal cut 1 cm from the midline. The hypothalami were bisected and frozen in isopentane cooled to -30 C. A unilateral hypothalamus from each animal was packed in dry ice and shipped to the University of Arizona, where it was stored at -80 C. One OVX + E animal was excluded from the study because of damage to the infundibular nucleus during tissue preparation. The remaining hypothalami were serially sectioned in a cryostat (12-µm thickness), and sections were mounted on gelatin-coated slides. The slides were stored at -80 C until hybridization.

In situ hybridization

Every 10th section was hybridized with [35S]-labeled 48-base synthetic oligonucleotide probes complementary to either human NKB or POMC mRNAs. All slides were processed within the same hybridization procedure. The sequence of the NKB probe was: CTGGCTGGACGCTCATCTTGCCCATAAGTCCCACAAAGAAATCATGCA (Dr. T. Bonner, personal communication). The POMC probe was complementary to bases 7,106–7,153 of the pre-POMC gene (17). The probes were synthesized on an automated DNA synthesizer (PE Applied Biosystems Incorporated model 380A; Foster City CA) and purified by PAGE gels. The probes were end-labeled using terminal deoxynucleotidyl transferase (Boehringer Mannheim, Indianapolis, IN) and [35S]deoxy-ATP (>1000 Ci/mmol/L; New England Nuclear, Boston, MA).

On the day of hybridization, sections were thawed to room temperature, fixed in 4% formalin-PBS for 5 min, placed in 0.25% acetic anhydride in 0.1 mol/L triethanolamine (pH = 8) for 10 min, and then delipidized in increasing concentrations of ethanol to 100%, followed by chloroform. The slides were then sequentially dipped in 100% and 95% ethanol and allowed to dry. Sections were incubated in a humid chamber overnight at 37 C in 106 dpm [35S]-labeled probe per 60 µL hybridization buffer under paraffin coverslips. The buffer consisted of 50% formamide, 600 mmol/L NaCl, 80 mmol/L Tris-HCL (pH 7.5), 4 mmol/L EDTA, 0.1% sodium pyrophosphate, 0.2% SDS, 0.2 mg/mL heparin sulfate, 10% dextran sulfate, and 100 mmol/L dithiothreitol. The following day, slides were washed four times in 2 x SSC (1 x SSC = 150 mmol/L NaCl and 15 mmol/L Na citrate)/50% formamide at 40 C for 15 min each and then 2 washes in 1 x SSC at room temperature for 30 min each. Slides were dipped into water, then 70% ethanol, and were air-dried. The slides were then dipped into NTB-3 under safelight conditions, (diluted 1:1 with water, Eastman Kodak Co., Rochester, NY) and stored in the dark at 4 C. Test slides were developed to determine optimum length of exposure. The NKB slides were developed after 2 months of exposure, and the POMC slides after 1 week of exposure by sequential immersion for 2 min in Dektol Developer (17 C, diluted 1:1 with water), water, and Fixer (EDF/EDP photochemicals, Eastman Kodak Co.). After rinsing, the sections were counterstained with toluidine blue.

The specificities of the probes have been previously demonstrated in human hypothalamic tissues using Northern analysis at the same conditions of stringency (9). In addition, no signal was present when monkey hypothalamic sections were hybridized either to NKB or POMC sense probes or in buffer without probe. The distribution of the labeled cells in the infundibular nucleus was similar to previous descriptions of NKB or POMC mRNAs in human or monkey hypothalamus (27, 28, 29). Finally, immunocytochemical studies have shown similar distributions of ß-endorphin- (30, 31), POMC- (32), and tachykinin-immunoreactive neurons (33) in the monkey infundibular nucleus.

Histochemistry for microglial cells

Monocytes and tissue histiocytes express unique, sodium fluoride-sensitive esterases such as {alpha}-napthyl butyrate esterase (34, 35, 36). Brain microglia are also identified by these enzymatic markers, consistent with the hematopoetic origin of these cells (37, 38). Esterase activity in microglia has been demonstrated in a variety of species, including mouse, rat, guinea pig, and human (37, 38, 39, 40). In culture, increased microglial esterase activity is correlated with increased phagocytic activity and the morphologic characteristics of activated microglia (40, 41). Resting microglia in uninjured brain also express esterase activity (38). An increase in the number of activated microglia in adult animals is a sensitive and reliable marker of neuropathology (42, 43) and a key feature of the estrogen-associated toxicity in rodents (24).

In the present study, microglial cells were identified by staining for {alpha}-napthyl butyrate esterase according to the method of Li et al. (34). Sections were fixed in cold 45% acetone, 10% buffered formalin for 30 sec, followed by three rinses in distilled water. They were air-dried and then incubated for 45 min in a substrate mixture consisting of 0.64 mol/L ethylene glycol monomethyl ether, 0.063 mol/L phosphate buffer (pH 6.3), 4.6 mmol/L {alpha}-napthyl butyrate, and 0.3 mmol/L hexazotized pararosanilin. Sections were rinsed three times in distilled water, counterstained in Weigert’s hematoxylin for 10 min, rinsed in running tap water for 5 min, dried, and coverslipped. A section from normal tonsil was used as a positive control for macrophage staining. Incubation with sodium fluoride, a specific inhibitor of esterase activity in monocytes, eliminated all specific staining in both tonsil and brain.

Computer microscope analysis

Before all procedures, slides were coded to prevent experimenter bias. Because our previous studies of POMC neurons in the human hypothalamus revealed considerable regional heterogeneity (11), we decided to limit our analysis to matched sections at easily identified hypothalamic levels. For measurements of NKB mRNA-containing neurons and microglial cells, two matched sections per animal were selected in the infundibular nucleus corresponding to section 840 of a monkey hypothalamic atlas (44). For analysis of POMC neurons, one matched section was selected corresponding to sections 800, 840, and 884 of Bleier’s atlas (44), to include the retrochiasmatic region and the anterior and posterior levels of the infundibular nucleus, respectively. Slides with significant sectioning artifact in the representative regions were excluded from microscopic analysis.

All labeled neurons (defined as 5X background) within each matched section were marked and counted and the perimeters digitized for calculations of form factor and cell area. These data were obtained using an image-combining computer microscope and Neurolucida Software (Microbrightfield, Baltimore, MD). First, the perimeter of the infundibular nucleus was manually digitized using a 4x Zeiss objective. The infundibular nucleus section was then scanned using a 63x Zeiss planapochromatic oil-immersion objective, and every labeled cell was counted and the somatic perimeter digitized. Neuronal profile areas were calculated from these digitized perimeters. The shapes of neuronal profiles were quantified using the form factor index, defined as the area of the profile divided by the area of a circle having the same perimeter [4{pi} x area/perimeter2, (45, 46)]. Thus, form factor index measures the degree to which the shape of a profile deviates from a perfect circle. Form factor index has also been used in the model of estradiol-valerate induced toxicity to assess degenerative changes in ß-endorphin immunoreactive neurons (47).

Twenty POMC neurons were selected in each matched section, for analysis of autoradiographic grains using a systematic sampling strategy. In this strategy, the entire infundibular nucleus was systematically scanned, and every nth labeled neuron (n = total number of labeled neurons within a section divided by 20) was analyzed. These data were collected with a Bioquant Meg IV image-analysis microscope system (R & M Biometrics, Nashville, TN) and BioQuant MEG IV counting and microdensitometry software (R & M Biometrics). Images were captured with a DAGE-MTI Series 65 black and white video camera attached to a Zeiss standard microscope with a 100x Zeiss planapo oil-immersion objective (Carl Zeiss, Berlin, Germany). The light intensity was first standardized, and the Nissl counterstain was suppressed with gel filters (Kodak Wratten 72B and 50; Eastman Kodak Co.), so that only dark silver grains were observed in the video image. The threshold was then adjusted so that only the silver grains were measured, and all the grains associated with each cell were counted. For each slide, background grains (approximately 2–3 grains/neuron) were measured in an adjacent region of nonlabeled tissue, and this value was subtracted from the number of grains for each neuron.

Statistical analysis

For all statistical analyses, the mean values for each animal were calculated. These values were then used to calculate the mean of each experimental group. Because no NKB neurons were detected in either the OVX + E or OVX + EP groups (see results below), the mean number of NKB neurons in the OVX group was compared with a hypothesized value of 0, using a t test. Differences in POMC parameters and the numbers of microglia between treatment groups were analyzed by one-way ANOVA. Because there were no differences in any of the parameters of POMC neurons among the various treatment groups, these data were pooled for further analysis of differences among hypothalamic regions. The differences among POMC neurons in the different hypothalamic regions were analyzed by one-way ANOVA with repeated measures. Tukey’s post tests were used, with {alpha} = 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
NKB neurons

Neurons containing NKB mRNA were identified within the infundibular nucleus of the OVX monkeys that did not receive HRT (Fig. 1Go). These neurons were located preferentially in the medial-ventral infundibular nucleus similar to the distribution of NKB mRNA-containing neurons in human and rat hypothalamus (29, 48). The NKB neurons in OVX animals exhibited prominent central nucleoli and well-defined Nissl substance with a mean profile area of 284.2 ± 18.2 µm2. These morphologic features were similar to the hypertrophied NKB neurons identified in the postmenopausal human hypothalamus (9).



View larger version (122K):
[in this window]
[in a new window]
 
Figure 1. Photomicrograph of neurons labeled with the NKB probe in the infundibular nucleus of an ovariectomized, untreated cynomolgus monkey. The grains mark the location of NKB mRNA, and the section has been counterstained with toluidine blue. Bar = 10 µm.

 
HRT resulted in a striking reduction in the number of neurons expressing NKB mRNA in the primate infundibular nucleus (Fig. 2Go). NKB neurons were identified in every infundibular nucleus section in the OVX group (18.3 ± 5.3 NKB neurons/section, mean ± SEM, n = 8). In contrast, there were no NKB neurons detected in the infundibular nucleus of any of the monkeys in either the OVX + E (n = 7) or OVX + EP (n = 5) groups (P < 0.004).



View larger version (120K):
[in this window]
[in a new window]
 
Figure 2. Darkfield photomicrographs of the infundibular nucleus of representative ovariectomized monkeys, either untreated (A and C) or receiving HRT (B and D). Sections have been hybridized to radiolabeled oligonucleotide probes complementary to NKB (A and B) or POMC (C and D) mRNAs. The clusters of silver grains show the location of labeled neurons. Administration of HRT to ovariectomized, cynomolgus monkeys resulted in complete suppression of NKB gene expression, whereas POMC gene expression was unaffected. Scale Bar = 200 µm.

 
POMC neurons

Neurons labeled with the POMC probe were identified throughout the retrochiasmatic region and infundibular nucleus. A few POMC neurons were also scattered dorsally in the ventromedial nucleus. HRT had no significant effect on the POMC system of neurons in the medial basal hypothalamus of ovariectomized, cynomolgus monkeys (Fig. 2Go). The number of neurons expressing POMC mRNA was not significantly altered by treatment with either estrogen or estrogen plus progesterone at any level of the hypothalamus. Furthermore, the sectional profile area and the number of grains/POMC neuron was unaltered by hormone replacement. Finally, analysis of form factor revealed no differences in the shape of POMC neurons among the three treatment groups.

There were qualitative morphological differences between POMC neurons in the retrochiasmatic area and infundibular nucleus. Similar to the human (11, 28), POMC neurons in the retrochiasmatic area were oriented parallel to the pituitary stalk, and appeared larger and more elongated than POMC neurons at more posterior levels (Fig. 3Go). Significant regional differences in POMC neurons were also revealed by the quantitative analysis (Table 1Go). In particular, POMC neurons in the retrochiasmatic area had significantly larger mean profile areas, were more elongated (decreased form factor index), and were more numerous than in the anterior infundibular nucleus. The POMC neurons in the anterior infundibular nucleus, in turn, had significantly larger mean profile areas, decreased form factor index, and were more numerous than in the posterior infundibular nucleus. All morphological differences across hypothalamic regions were independent of treatment group.



View larger version (53K):
[in this window]
[in a new window]
 
Figure 3. Photomicrographs of neurons containing POMC mRNA in the retrochiasmatic region (A), and anterior (B) and posterior (C) divisions of the infundibular nucleus. POMC neuronal profiles in the retrochiasmatic region were larger and more oval than the neurons in the infundibular nucleus. Bar = 10 µm.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Regional differences in POMC neuronal morphology and gene expression in the medial basal hypothalamus of cynomolgus monkeys

 
Microglial cells

{alpha}-Napthyl butyrate esterase histochemistry revealed intensely-stained microglial cell bodies and short microglial processes in the hypothalamus and adjacent brain (Fig. 4Go). Many of the cell bodies of microglial cells contained dark, granular inclusions. Consistent with previous reports, microglial morphology showed considerable variation (49, 50). Microglia in gray matter were round to oval, measuring about 9 µm in diameter; whereas in white matter tracts, microglia were thin and elongated. There were no positive cells in the cynomolgus monkey brains exhibiting macrophage morphology (eccentric nuclei and round, well-defined cytoplasmic contours). In contrast, in the control sections from human tonsil, scattered macrophages were observed. Addition of sodium fluoride to the incubation mixture eliminated the specific staining in tonsil and in cynomolgus monkey brain.



View larger version (138K):
[in this window]
[in a new window]
 
Figure 4. Photomicrograph of microglial cells stained for {alpha}-napthyl butyrate esterase in the gray matter of a cynomolgus monkey. Bar = 30 µm.

 
Microglia were evenly distributed throughout the infundibular nucleus in both untreated and treated monkeys, and no differences in microglial morphology were observed among the groups. In particular, cells with the morphologic features of activated microglia (macrophages) were not identified in the infundibular nucleus of any animal. Finally, there were no significant differences in the density of microglia in the infundibular nucleus among groups (OVX: 50.9 ± 16.0 cells/mm2; OVX + E: 45.0 ± 11.5 cells/mm2; OVX + EP: 36.2 ± 22.5 cells/mm2; mean + SEM).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The present study provides the first information on the effects of long-term HRT on neuropeptide gene expression in the primate hypothalamus. The ovariectomized, cynomolgus monkey served as a model for postmenopausal women and received replacement protocols designed to mimic current therapeutic regimens. Young, ovariectomized monkeys represent an excellent model of postmenopausal women for several reasons. Unlike rodents, monkeys exhibit menstrual cycles that are similar in length to those in women (51, 52, 53, 54), and they eventually undergo menopause (55). In addition, the endocrine profile (gonadotropin hypersecretion and ovarian steroid withdrawal) and symptomatology (hot flushes) are similar among ovariectomized young monkeys, oophorectomized young women, and postmenopausal women (56, 57, 58, 59, 60, 61). Indeed, ovariectomy in young monkeys (and women) is commonly referred to as a surgical menopause (3).

Treatment of young ovariectomized monkeys with either conjugated estrogen or estrogen plus medroxyprogesterone caused a marked decrease in the number of infundibular neurons expressing NKB gene transcripts. The extent of suppression of NKB neurons was dramatic: no NKB neurons were detected in the infundibular nucleus of any of the animals receiving HRT. In contrast, in the ovariectomized, nontreated group, neurons containing NKB mRNA were observed in every animal. These data provide strong evidence that the increased NKB gene expression detected in the infundibular nucleus of postmenopausal women is secondary to ovarian failure and the loss of ovarian estrogen secretion.

Our findings are consistent with studies showing that continuous estrogen treatment results in decreased numbers of NKB-immunoreactive neurons in the rat arcuate nucleus, the homologue of the primate infundibular nucleus (62). Conversely, gonadectomy of both male and female rats increases the number of arcuate neurons expressing NKB gene transcripts (48, 63). Tachykinin-immunoreactive neurons in the rat arcuate nucleus contain androgen (64) and estrogen receptors (65), and NKB mRNA-containing neurons in the human infundibular nucleus express estrogen receptor gene transcripts (9). These data indicate that the inhibitory actions of gonadal steroids on NKB gene expression could be mediated via intranuclear estrogen receptors. It is not known whether the effect of estrogen on NKB gene expression is secondary to repression of gene transcription or decreased NKB mRNA stability. In the anterior pituitary gland, however, estradiol inhibits ovine FSH-ß mRNA synthesis by direct transcriptional repression (66).

Because previous studies have shown that levels of mRNA correlate with changes in neuronal activity (67, 68, 69, 70, 71), the present study suggests that estrogen decreases the activity of infundibular NKB neurons in ovariectomized monkeys. Electrophysiological studies have also provided evidence that activity of infundibular neurons is inhibited by estradiol in ovariectomized monkeys. In particular, the rhythmic bursts of multiunit activity that are associated with the pulsatile release of LH (the GnRH pulse generator) are dramatically suppressed by estrogen treatment (72, 73, 74). The neuropeptide and/or neurotransmitter phenotype of the pulse generator cells is presently unknown. There is considerable overlap, however, between the location of NKB neurons and the GnRH pulse generator in the monkey infundibular nucleus (75). These considerations, combined with the inhibitory effects of estrogen on both pulse generator activity and the cellular levels of NKB mRNA, raise the possibility that infundibular NKB neurons could contribute to the multiunit activity that is associated with GnRH pulses in the primate hypothalamus.

In contrast to the dramatic suppressive effect of HRT on the NKB system of neurons, no changes were detected in the POMC neurons in either the infundibular nucleus or retrochiasmatic area. These findings are in agreement with a previous study on the effects of castration and testosterone replacement on POMC gene expression in the infundibular nucleus of male macaques (27). In that study, hormone replacement of castrated animals did not produce significant changes in the number of autoradiographic grains per neuron at three comparable levels of the medial basal hypothalamus. Testosterone replacement did produce a significant increase in POMC autoradiographic grains in the rostral monkey hypothalamus superior to optic chiasm (27). This level, however, was not examined in the present study. Although we cannot exclude the possibility that different replacement or sampling regimens might have produced detectable changes in POMC neurons, clearly the present paradigm was very effective in demonstrating estrogen modulation of NKB gene expression. The failure of HRT to induce a change in POMC gene expression in the infundibular nucleus in young, ovariectomized monkeys suggests that factors other than ovarian steroid withdrawal, such as aging, may be responsible for the decline in POMC gene expression in postmenopausal women.

The morphology of POMC neurons in the monkey hypothalamus was regionally heterogeneous, with the neurons in the retrochiasmatic region appearing larger and more elongated than those in the infundibular nucleus. Because these observations were made solely from coronal sections, it is possible that the regional differences in form factor and cell size reflect differences in cell orientation. In our previous human studies, however, similar observations were made using both sagittal and coronal sections (11, 28). Corresponding shape and size differences of POMC neurons have not been reported in the rodent, but regional heterogeneity has been described in the regulation of POMC gene expression (76, 77, 78). In addition, there are differences in POMC axonal projections, depending on their rostral-caudal location within the medial basal hypothalamus of the rat (78, 79). These findings suggest that subpopulations of POMC neurons may be organized topographically in the hypothalamus and could provide an explanation for the diverse set of functions attributed to this neuropeptide system.

We found no evidence that continuous estrogen replacement produced hypothalamic toxicity in primates. The toxic effect of estradiol on the reproductive axis has been demonstrated by a variety of methods, including implantation of silastic capsules (24, 80), oral administration (81), and injections of estradiol valerate (82, 83). The best-characterized model of estrogen toxicity has been the estradiol-valerate treated rat. In these rats, a progressive arcuate lesion develops that is characterized by increased microglial and astrocytic markers (82, 83), degeneration of axons and dendrites (82), and reduction in the number of ß-endorphin immunoreactive neurons (47). In addition, the remaining ß-endorphin-immunoreactive neurons exhibited morphological features of degeneration, including a significant reduction in the form factor index (47).

In the present study, we evaluated two sensitive and specific indicators of estrogen toxicity based on the rodent model: POMC neurons and microglial cells. No change was detected in the number of infundibular neurons expressing POMC gene transcripts in monkeys receiving either estrogen or estrogen plus progesterone. In addition, no differences between treated and untreated groups were observed in the size or autoradiographic grain density of POMC neurons. Furthermore, no changes were detected in the shape (form factor index) of POMC neurons in the hormone-replaced animals. Finally, there were no alterations in the numbers of microglial cells in the infundibular nucleus of ovariectomized monkeys with or without HRT, and no evidence of activated microglia in these animals. Thus, we found no evidence for a neuropathological effect of sustained, unopposed estrogen in the primate hypothalamus.

In summary, the present data suggest that different mechanisms mediate two of the major changes observed in the hypothalamus of postmenopausal women. Clearly, NKB gene expression in the primate hypothalamus is exquisitely sensitive to alterations in circulating estrogen. These data strongly support the hypothesis that increased NKB gene expression in postmenopausal women is caused by estrogen withdrawal. In contrast to the dramatic changes in the NKB system, there were no effects of hormone replacement on several parameters of POMC neurons in the infundibular nucleus. Thus, the decrease in POMC neurons in postmenopausal women may be caused by factors other than ovarian steroid withdrawal, such as hypothalamic aging. Although loss of POMC neurons and reactive microglial changes have been linked to estrogen exposure in the rat, we found no evidence for estrogen toxicity in primates treated with continuous replacement therapy. These findings are of particular importance given the millions of women currently receiving HRT and the increasing popularity of the continuous replacement regimens.


    Acknowledgments
 
The authors gratefully acknowledge the donation of cynomolgus monkey hypothalami by Dr. Thomas Clarkson at the Comparative Medicine Clinical Research Center at the Wake Forest School of Medicine. Dr. Tom Grogan provided expert advice on histochemical identification of microglial cells. We also thank Drs. Nate McMullen and Seymour Reichlin for useful comments on an earlier version of this manuscript. Graciella Gutierrez and Shane V. Uswandi provided expert technical assistance.


    Footnotes
 
1 This work was supported by NIH Grant AG-09214. Back

2 Recipient of a Predoctoral Fellowship from the Robert S. Flinn Biomedical Research Initiative. Back

Received November 9, 1998.

Revised February 1, 1999.

Accepted February 8, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Rosenberg L. 1993 Hormone replacement therapy: the need for reconsideration. Am J Public Health. 83:1670–1673.[Abstract/Free Full Text]
  2. Speroff L. 1993 Menopause and hormone replacement therapy. Clin Geriatr Med. 9:33–54.[Medline]
  3. Phillips SM, Sherwin BB. 1992 Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:485–495.[CrossRef][Medline]
  4. Brenner DE, Kukull WA, Stergachis A, et al. 1994 Postmenopausal estrogen replacement therapy and the risk of Alzheimer’s Disease: a population-based case-control study. Am J Epidemiol. 140:262–267.[Abstract/Free Full Text]
  5. Belchetz PE. 1994 Hormonal treatment of postmenopausal women. N Engl J Med. 330:1062–1071.[Free Full Text]
  6. Evans MP, Fleming KC, Evans JM. 1995 Hormone replacement therapy: management of common problems. Mayo Clin Proc. 70:800–805.[Abstract]
  7. Sheehan HL, Kovács K. 1966 The subventricular nucleus of the human hypothalamus. Brain. 89:589–614.[Free Full Text]
  8. Rance NE, McMullen NT, Smialek JE, Price DL, Young III WS. 1990 Postmenopausal hypertrophy of neurons expressing the estrogen receptor gene in the human hypothalamus. J Clin Endocrinol Metab. 71:79–85.[Abstract/Free Full Text]
  9. Rance NE, Young III WS. 1991 Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women. Endocrinology. 128:2239–2247.[Abstract/Free Full Text]
  10. Rance NE, Uswandi SV. 1996 Gonadotropin-releasing hormone gene expression is increased in the medial basal hypothalamus of postmenopausal women. J Clin Endocrinol Metab. 81:3540–3546.[Abstract]
  11. Abel TW, Rance NE. 1999 Proopiomelanocortin (POMC) gene expression is decreased in the hypothalamus of postmenopausal women. Mol Brain Res. In press.
  12. Wardlaw SL, Wehrenberg WB, Ferin M, Antunes JL, Frantz AG. 1982 Effect of sex steroids on ß-endorphin in hypophyseal portal blood. J Clin Endocrinol Metab. 55:877–881.[Abstract/Free Full Text]
  13. Koob GF, Bloom FE. 1983 Behavioural effects of opioid peptides. Br Med Bull. 39:89–94.[Free Full Text]
  14. Grossman A. 1983 Brain opiates and neuroendocrine function. Clin Endocrinol Metab. 12:725–746.[Medline]
  15. Ferin M, Van Vugt D, Wardlaw S. 1984 The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Prog Horm Res. 40:441–485.
  16. Howlett TA, Rees LH. 1987 Endogenous opioid peptides and human reproduction. In: Clarke JR, ed. Oxford reviews of reproductive biology. Oxford: Clarendon Press; 260–293.
  17. Takahashi H, Hakamata Y, Watanabe Y, Kikuno R, Miyata T, Numa S. 1983 Complete nucleotide sequence of the human corticotropin-ß-lipotropin precursor gene. Nucleic Acids Res. 11:6847–6858.[Abstract/Free Full Text]
  18. Lipton JM, Catania A, Delgado R. 1998 Peptide modulation of inflammatory processes within the brain. Neuroimmunomodulation. 5:178–183.[CrossRef][Medline]
  19. Mountjoy KG, Wong J. 1997 Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol Cell Endocrinol. 128:171–177.[CrossRef][Medline]
  20. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:165–168.[CrossRef][Medline]
  21. Huszar D, Lynch CA, Fairchild-Huntress V, et al. 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:131–141.[CrossRef][Medline]
  22. Finch CE, Felicio LS, Mobbs CV, Nelson JF. 1984 Ovarian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr Rev. 5:467–497.[Abstract/Free Full Text]
  23. Desjardins GC, Beaudet A, Meaney MJ, Brawer JR. 1995 Estrogen-induced hypothalamic beta-endorphin neuron loss: a possible model of hypothalamic aging. Exp Gerontol. 30:253–267.[CrossRef][Medline]
  24. Brawer J, Schipper H, Robaire B. 1983 Effects of long term androgen and estradiol exposure on the hypothalamus. Endocrinology. 112:194–199.[Abstract/Free Full Text]
  25. Williams JK, Anthony MS, Honoré EK, et al. 1995 Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 15:827–836.[Abstract/Free Full Text]
  26. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. 1997 Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 17:217–221.[Abstract/Free Full Text]
  27. Adams LA, Vician L, Clifton DK, Steiner RA. 1991 Testosterone regulates proopiomelanocortin gene expression in the primate brain. Endocrinology. 128:1881–1886.[Abstract/Free Full Text]
  28. Sukhov RR, Walker LC, Rance NE, Price DL, Young III WS. 1995 Opioid precursor gene expression in the human hypothalamus. J Comp Neurol. 353:604–622.[CrossRef][Medline]
  29. Chawla MK, Gutierrez GM, Young III WS, McMullen NT, Rance NE. 1997 Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain. J Comp Neurol. 384:429–442.[CrossRef][Medline]
  30. Lewis ME, Khachaturian H, Akil H, Watson SJ. 1984 Anatomical relationship between opioid peptides and receptors in rhesus monkey brain. Brain Res Bull. 13:801–812.[CrossRef][Medline]
  31. Bethea CL, Widmann AA. 1996 Immunohistochemical detection of progestin receptors in hypothalamic ß-endorphin and substance P neurons of steroid-treated monkeys. Neuroendocrinology. 63:132–141.[Medline]
  32. Khachaturian H, Lewis ME, Haber SN, Akil H, Watson SJ. 1984 Proopiomelanocortin peptide immunocytochemistry in rhesus monkey brain. Brain Res Bull. 13:785–800.[CrossRef][Medline]
  33. Ronnekleiv OK, Kelly MJ, Eskay RL. 1984 Distribution of immunoreactive substance P neurons in the hypothalamus and pituitary of the rhesus monkey. J Comp Neurol. 224:51–59.[CrossRef][Medline]
  34. Li CY, Lam KW, Yam LT. 1973 Esterases in human leukocytes. J Histochem Cytochem. 21:1–12.[Abstract]
  35. Gignac SM, Drexler HG. 1990 Monocyte-specific esterase isoenzyme demonstrated by isoelectric focusing. Electrophoresis. 11:819–824.[CrossRef][Medline]
  36. Patel D, Scott CS. 1991 Inhibitor studies of purified haemopoietic (myeloid) cell esterases. Evidence for the existence of distinct enzyme species. Biochem Pharmacol. 42:1577–1585.[CrossRef][Medline]
  37. Oehmichen M, Wiethölter H, Gencic M. 1980 Cytochemical markers for mononuclear phagocytes as demonstrated in reactive microglia and globoid cells. Acta Histochem. 66:243–252.[Medline]
  38. Ling EA, Kaur C, Wong WC. 1982 Light and electron microscopic demonstration of non-specific esterase in amoeboid microglial cells in the corpus callosum in postnatal rats: a cytochemical link to monocytes. J Anat. 135:385–394.[Medline]
  39. Zucker-Franklin D, Warfel A, Grusky G, Frangione B, Teitel D. 1987 Novel monocyte-like properties of microglial/astroglial cells. Constitutive secretion of lysozyme and cystatin-C. Lab Invest. 57:176–185.[Medline]
  40. Di Pucchio T, Ennas MG, Presta M, Lauro GM. 1996 Basic fibroblast growth factor modulates in vitro differentiation of human fetal microglia. Neuroreport. 7:2813–2817.[Medline]
  41. Chamak B, Mallat M. 1991 Fibronectin and laminin regulate the in vitro differentiation of microglial cells. Neuroscience. 45:513–527.[CrossRef][Medline]
  42. Dolman CL. 1991 Microglia. In: Davis RL, Robertson DM, eds. Textbook of neuropathology. Baltimore: Williams and Wilkins; 141–163.
  43. Duchen LW. 1992 General pathology of neurons and neuroglia. In: Adams JH, Duchen LW, eds. Greenfield’s europathology. New York: Oxford University Press; 1–68.
  44. Bleier R. 1984 The hypothalamus of the rhesus monkey, a cytoarchitectonic atlas. Madison, WI: The University of Wisconsin Press; 1–122.
  45. Arbuthnott ER, Ballard KJ, Boyd IA, Kalu KU. 1980 Quantitative study of the non-circularity of myelinated peripheral nerve fibres in the cat. J Physiol (Lond). 308:99–123.[Abstract/Free Full Text]
  46. Fernández E, Cuenca N, De Juan J. 1991 A useful programme in BASIC for axonal morphometry with introduction of new cytoskeletal parameters. J Neurosci Methods. 39:271–289.[CrossRef][Medline]
  47. Desjardins GC, Brawer JR, Beaudet A. 1993 Estradiol is selectively neurotoxic to hypothalamic beta-endorphin neurons. Endocrinology. 132:86–93.[Abstract/Free Full Text]
  48. Rance NE, Bruce TR. 1994 Neurokinin B gene expression is increased in the arcuate nucleus of ovariectomized rats. Neuroendocrinology. 60:337–345.[Medline]
  49. Lawson LJ, Perry VH, Dri P, Gordon S. 1990 Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 39:151–170.[CrossRef][Medline]
  50. Mander TH, Morris JF. 1995 Immunophenotypic evidence for distinct populations of microglia in the rat hypothalamo-neurohypophysial system. Cell Tissue Res. 280:665–673.[Medline]
  51. MacDonald GJ. 1971 Reproductive patterns of three species of macaques. Fertil Steril. 22:373–377.[Medline]
  52. Jewett DA, Dukelow WR. 1972 Cyclicity and gestation length of Macaca fascicularis. Primates. 13:327–330.[CrossRef]
  53. Williams RF, Hodgen GD. 1982 The reproductive cycle in female macaques. Am J Primatol. [Suppl]1 :181–192.
  54. Robinson JA, Goy RW. 1986 Steroid hormones and the ovarian cycle. In: Dukelow RW, Erwin J, eds. Comparative Primate Biology. Volume 3: Reproduction and Development. New York: Alan R. Liss; 63–91.
  55. Hodgen GD, Goodman AL, O’Connor A, Johnson DK. 1977 Menopause in rhesus monkeys: model for study of disorders in the human climacteric. Am J Obstet Gynecol. 127:581–584.[Medline]
  56. Wallach EE, Root AW, Garcia C-R. 1970 Serum gonadotropin responses to estrogen and progestogen in recently castrated human females. J Clin Endocrinol Metab. 31:376–381.[Abstract/Free Full Text]
  57. Monroe SE, Jaffe RB, Midgley Jr AR. 1972 Regulation of human gonadotropins. XIII. Changes in serum gonadotropins in menstruating women in response to oophorectomy. J Clin Endocrinol Metab. 34:420–422.[Abstract/Free Full Text]
  58. Chakravarti S, Collins WP, Newton JR, Oram DH, Studd JWW. 1977 Endocrine changes and symptomatology after oophorectomy in premenopausal women. Br J Obstet Gynaecol. 84:769–775.[Medline]
  59. Jelinek J, Kappen A, Schönbaum E, Lomax P. 1984 A primate model of human postmenopausal hot flushes. J Clin Endocrinol Metab. 59:1224–1228.[Abstract/Free Full Text]
  60. Sherwin BB, Gelfand MM. 1984 Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flushes in the surgical menopause. Am J Obstet Gynecol. 148:552–557.[Medline]
  61. Dierschke DJ. 1985 Temperature changes suggestive of hot flushes in rhesus monkeys: preliminary observations. J Med Primatol. 14:271–280.[Medline]
  62. Akesson TR, Sternini C, Micevych PE. 1991 Continuous estrogen decreases neurokinin B expression in the rat arcuate nucleus. Mol Cell Neurosci. 2:299–304.[CrossRef]
  63. Danzer SC, Price RO, McMullen NT, Rance NE 1999 Sex steroid modulation of neurokinin B gene expression in the arcuate nucleus of adult male rat. Mol Brain Res. 66:200–204.[Medline]
  64. Ciofi P, Krause JE, Prins GS, Mazzuca M. 1994 Presence of nuclear androgen receptor-like immunoreactivity in neurokinin B-containing neurons of the hypothalamic arcuate nucleus of the adult male rat. Neurosci Lett. 182:193–196.[CrossRef][Medline]
  65. Akesson TR, Micevych PE. 1988 Estrogen concentration by substance P-immunoreactive neurons in the medial basal hypothalamus of the female rat. J Neurosci Res. 19:412–419.[CrossRef][Medline]
  66. Miller CD, Miller WL. 1996 Transcriptional repression of the ovine follicle-stimulating hormone-ß gene expression by 17ß-estradiol. Endocrinology. 137:3437–3446.[Abstract]
  67. Comb M, Hyman SE, Goodman HM. 1987 Mechanisms of trans-synaptic regulation of gene expression. Trends Neurosci. 10:473–478.[CrossRef]
  68. Young III WS, Zoeller RT. 1987 Neuroendocrine gene expression in the hypothalamus: in situ hybridization histochemical studies. Cell Mol Neurobiol. 7:353–366.[CrossRef][Medline]
  69. Blum M, McEwen BS, Roberts JL. 1987 Transcriptional analysis of tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic neurons of the rat arcuate nucleus after estrogen treatment. J Biol Chem. 262:817–821.[Abstract/Free Full Text]
  70. Uhl GR, Nishimori T. 1990 Neuropeptide gene expression and neural activity: assessing a working hypothesis in nucleus caudalis and dorsal horn neurons expressing preproenkephalin and preprodynorphin. Cell Mol Neurobiol. 10:73–98.[CrossRef][Medline]
  71. Petersen SL, McCrone S, Keller M, Gardner E. 1991 Rapid increase in LHRH mRNA levels following NMDA. Endocrinology. 129:1679–1681.[Abstract/Free Full Text]
  72. Kesner JS, Wilson RC, Kaufman J-M, et al. 1987 Unexpected responses of the hypothalamic gonadotropin-releasing hormone "pulse generator" to physiological estradiol inputs in the absence of the ovary. Proc Natl Acad Sci USA. 84:8745–8749.[Abstract/Free Full Text]
  73. O’Byrne KT, Chen M-D, Nishihara M, et al. 1993 Ovarian control of gonadotropin hormone-releasing hormone pulse generator activity in the rhesus monkey: duration of the associated hypothalamic signal. Neuroendocrinology. 57:588–592.[Medline]
  74. Ördög T, Knobil E. 1995 Estradiol and the inhibition of hypothalamic gonadotropin-releasing hormone pulse generator activity in the rhesus monkey. Proc Natl Acad Sci USA. 92:5813–5816.[Abstract/Free Full Text]
  75. Silverman A-J, Wilson R, Kesner JS, Knobil E. 1986 Hypothalamic localization of multiunit electrical activity associated with pulsatile LH release in the rhesus monkey. Neuroendocrinology. 44:168–171.[Medline]
  76. Chowen-Breed JA, Clifton DK, Steiner RA. 1989 Regional specificity of testosterone regulation of proopiomelanocortin gene expression in the arcuate nucleus of the male rat brain. Endocrinology. 124:2875–2881.[Abstract/Free Full Text]
  77. Tong Y, Zhao H, Labrie F, Pelletier G. 1990 Regulation of proopiomelanocortin messenger ribonucleic acid content by sex steroids in the arcuate nucleus of the female rat brain. Neurosci Lett. 112:104–108.[CrossRef][Medline]
  78. Cheung S, Hammer Jr RP. 1995 Gonadal steroid hormone regulation of proopiomelanocortin gene expression in arcuate neurons that innervate the medial preoptic area of the rat. Neuroendocrinology. 62:283–292.[CrossRef][Medline]
  79. Yoshida M, Taniguchi Y. 1988 Projection of pro-opiomelanocortin neurons from the rat arcuate nucleus to the midbrain central gray as demonstrated by double staining with retrograde labeling and immunohistochemistry. Arch Histol Cytol. 51:175–183.[Medline]
  80. Mobbs CV, Flurkey K, Gee DM, Yamamoto K, Sinha YN, Finch CE. 1984 Estradiol-induced adult anovulatory syndrome in female C57BL/6J mice: age-like neuroendocrine, but not ovarian, impairments. Biol Reprod. 30:556–563.[Abstract]
  81. Kohama SG, Anderson CP, Osterburg HH, May PC, Finch CE. 1989 Oral administration of estradiol to young C57BL/6J mice induces age-like neuroendocrine dysfunctions in the regulation of estrous cycles. Biol Reprod. 41:227–232.[Abstract]
  82. Brawer JR, Naftolin F, Martin J, Sonnenschein C. 1978 Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology. 103:501–512.[Abstract/Free Full Text]
  83. Brawer JR, Schipper H, Naftolin F. 1980 Ovary-dependent degeneration in the hypothalamic arcuate nucleus. Endocrinology. 107:274–279.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
R. L. Goodman, M. N. Lehman, J. T. Smith, L. M. Coolen, C. V. R. de Oliveira, M. R. Jafarzadehshirazi, A. Pereira, J. Iqbal, A. Caraty, P. Ciofi, et al.
Kisspeptin Neurons in the Arcuate Nucleus of the Ewe Express Both Dynorphin A and Neurokinin B
Endocrinology, December 1, 2007; 148(12): 5752 - 5760.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Rometo, S. J. Krajewski, M. Lou Voytko, and N. E. Rance
Hypertrophy and Increased Kisspeptin Gene Expression in the Hypothalamic Infundibular Nucleus of Postmenopausal Women and Ovariectomized Monkeys
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2744 - 2750.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. M. Escobar, S. J. Krajewski, T. Sandoval-Guzman, M. L. Voytko, and N. E. Rance
Neuropeptide Y Gene Expression Is Increased in the Hypothalamus of Older Women
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2338 - 2343.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hestiantoro and D. F. Swaab
Changes in Estrogen Receptor-{alpha} and -{beta} in the Infundibular Nucleus of the Human Hypothalamus Are Related to the Occurrence of Alzheimer's Disease Neuropathology
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1912 - 1925.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. L. Dellovade and I. Merchenthaler
Estrogen Regulation of Neurokinin B Gene Expression in the Mouse Arcuate Nucleus Is Mediated by Estrogen Receptor {alpha}
Endocrinology, February 1, 2004; 145(2): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Krajewski, T. W. Abel, M. L. Voytko, and N. E. Rance
Ovarian Steroids Differentially Modulate the Gene Expression of Gonadotropin-Releasing Hormone Neuronal Subtypes in the Ovariectomized Cynomolgus Monkey
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 655 - 662.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. L. Bellino and P. M. Wise
Nonhuman Primate Models of Menopause Workshop
Biol Reprod, January 1, 2003; 68(1): 10 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gill, J. L. Sharpless, K. Rado, and J. E. Hall
Evidence That GnRH Decreases with Gonadal Steroid Feedback but Increases with Age in Postmenopausal Women
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2290 - 2296.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
C. V. Mobbs, G. A. Bray, R. L. Atkinson, A. Bartke, C. E. Finch, E. Maratos-Flier, J. N. Crawley, and J. F. Nelson
Neuroendocrine and Pharmacological Manipulations to Assess How Caloric Restriction Increases Life Span
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2001; 56(90001): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M.-L. Goubillon, R. A. Forsdike, J. E. Robinson, P. Ciofi, A. Caraty, and A. E. Herbison
Identification of Neurokinin B-Expressing Neurons as an Highly Estrogen-Receptive, Sexually Dimorphic Cell Group in the Ovine Arcuate Nucleus
Endocrinology, November 1, 2000; 141(11): 4218 - 4225.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abel, T. W.
Right arrow Articles by Rance, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abel, T. W.
Right arrow Articles by Rance, N. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals